110 related articles for article (PubMed ID: 24199803)
1. Angiogenesis at the mold-host interface: a potential key to understanding and treating invasive aspergillosis.
Ben-Ami R
Future Microbiol; 2013 Nov; 8(11):1453-62. PubMed ID: 24199803
[TBL] [Abstract][Full Text] [Related]
2. Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.
Ben-Ami R; Albert ND; Lewis RE; Kontoyiannis DP
J Infect Dis; 2013 Apr; 207(7):1066-74. PubMed ID: 23303813
[TBL] [Abstract][Full Text] [Related]
3. Azole resistance in Aspergillus fumigatus: a new challenge in the management of invasive aspergillosis?
Snelders E; Melchers WJ; Verweij PE
Future Microbiol; 2011 Mar; 6(3):335-47. PubMed ID: 21449843
[TBL] [Abstract][Full Text] [Related]
4. Implications of hypoxic microenvironments during invasive aspergillosis.
Wezensky SJ; Cramer RA
Med Mycol; 2011 Apr; 49 Suppl 1(Suppl 1):S120-4. PubMed ID: 20560863
[TBL] [Abstract][Full Text] [Related]
5. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
6. The contribution of Aspergillus fumigatus stress responses to virulence and antifungal resistance.
Brown NA; Goldman GH
J Microbiol; 2016 Mar; 54(3):243-53. PubMed ID: 26920884
[TBL] [Abstract][Full Text] [Related]
7. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection.
Ben-Ami R; Lewis RE; Kontoyiannis DP
Br J Haematol; 2010 Aug; 150(4):406-17. PubMed ID: 20618330
[TBL] [Abstract][Full Text] [Related]
8. Secretion stress and antifungal resistance: an Achilles' heel of Aspergillus fumigatus?
Richie DL; Feng X; Krishnan K; Askew DS
Med Mycol; 2011 Apr; 49 Suppl 1():S101-6. PubMed ID: 20608779
[TBL] [Abstract][Full Text] [Related]
9. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis.
Kaur S; Gupta VK; Thiel S; Sarma PU; Madan T
Clin Exp Immunol; 2007 May; 148(2):382-9. PubMed ID: 17335555
[TBL] [Abstract][Full Text] [Related]
10. New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches.
Obar JJ; Hohl TM; Cramer RA
Cytokine; 2016 Aug; 84():63-73. PubMed ID: 27253487
[TBL] [Abstract][Full Text] [Related]
11. Aspergillus fumigatus and Aspergillosis in 2019.
Latgé JP; Chamilos G
Clin Microbiol Rev; 2019 Dec; 33(1):. PubMed ID: 31722890
[No Abstract] [Full Text] [Related]
12. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
Hachem RY; Kontoyiannis DP; Boktour MR; Afif C; Cooksley C; Bodey GP; Chatzinikolaou I; Perego C; Kantarjian HM; Raad II
Cancer; 2004 Oct; 101(7):1594-600. PubMed ID: 15378491
[TBL] [Abstract][Full Text] [Related]
13. New insights into invasive aspergillosis--from the pathogen to the disease.
Binder U; Lass-Flörl C
Curr Pharm Des; 2013; 19(20):3679-88. PubMed ID: 23278533
[TBL] [Abstract][Full Text] [Related]
14. Discovering the infectome of human endothelial cells challenged with Aspergillus fumigatus applying a mass spectrometry label-free approach.
Curty N; Kubitschek-Barreira PH; Neves GW; Gomes D; Pizzatti L; Abdelhay E; Souza GH; Lopes-Bezerra LM
J Proteomics; 2014 Jan; 97():126-40. PubMed ID: 23886778
[TBL] [Abstract][Full Text] [Related]
15. Azole resistant Aspergillus fumigatus: an emerging problem.
Lelièvre L; Groh M; Angebault C; Maherault AC; Didier E; Bougnoux ME
Med Mal Infect; 2013 Apr; 43(4):139-45. PubMed ID: 23562488
[TBL] [Abstract][Full Text] [Related]
16. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
17. Aspergillus fumigatus: contours of an opportunistic human pathogen.
McCormick A; Loeffler J; Ebel F
Cell Microbiol; 2010 Nov; 12(11):1535-43. PubMed ID: 20716206
[TBL] [Abstract][Full Text] [Related]
18. Triazole fungicides and the selection of resistance to medical triazoles in the opportunistic mould Aspergillus fumigatus.
Verweij PE; Kema GH; Zwaan B; Melchers WJ
Pest Manag Sci; 2013 Feb; 69(2):165-70. PubMed ID: 23109245
[TBL] [Abstract][Full Text] [Related]
19. Aspergillus fumigatus biofilms in the clinical setting.
Müller FM; Seidler M; Beauvais A
Med Mycol; 2011 Apr; 49 Suppl 1():S96-S100. PubMed ID: 21254964
[TBL] [Abstract][Full Text] [Related]
20. Advances against aspergillosis.
Steinbach WJ; Stevens DA; Denning DW; Moss RB
Clin Infect Dis; 2003 Oct; 37 Suppl 3():S155-6. PubMed ID: 12975750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
